IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
18 hedge funds and large institutions have $5.24M invested in Interpace Biosciences, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
SCM
Sio Capital Management
New York
|
-$1.32M |
2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$320K |
3 |
Citadel Advisors
Miami,
Florida
|
-$26K |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$21K |
5 |
UBS Group
Zurich,
Switzerland
|
-$6.18K |